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Dorothy E. Rob<rls

Race, Gender, and Genetic Technologies: A New
Reproductive Dystopia?

I

n the 1980s, Margaret Atwood, Gena Corea, and other feminists imag

ined dystopias in which white women's reproduction was valued and
privileged and the reproduction of women of color was devalued and

exploited. In The Handmaid's Tale, published in 1985,Atwood envisioned
the repressive Republic of Gilead, where handmaids were forced to serve
as breeders for elite men and their infertile wives in order to perpetuate
the white race, while blacks, as well as handmaids who fuiled to bear
children, were exiled to toxic colonies (Atwood 1985). That same year,
in

The Mother Machine, Corea predicted that white women would hire

surrogates of color in reproductive brothels to be implanted with their
eggs and gestate their babies at low cost (Corea 1985).
Two decades later, feminist scholars have continued to critique the
hierarchy that anthropologist Rayna Rapp aptly calls "stratified repro
duction" by contrasting the opposing relationships of white women and
women of color to reproduction-assisting technologies (1999, 310). At
the turn of the twenty-first century, even more advanced reproductive
technologies that combine assisted conception with genetic selection, or
reprogenetics, threaten to intensifY this opposition (Roberts 2005; Parens
and Knowles 2007). With preirnplantation genetic diagnosis (PGD), cli
nicians can biopsy a single cell from early embryos, diagnose it for the
chance of having hundreds of genetic conditions, and select for implan
tation only those embryos at low risk of having these conditions (Rob
ertson 2003; Spar 2006; Singer 2007). As Reprogeneties, a New Jersey
genetics laboratory that specializes in·PGD, puts it, this technique allows
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for the "replacement to rhe patient of those embryos classified by genetic
diagnosis as normal. "1
At a time when wealthy white women have access to technologies that
assist them in having children who not only are genetically related to them
or their partners but have also been genetically screened, various laws and
policies discourage women of color from having children at all (Roberts

1998; Smith 2007). 1\J; Rapp stated at a Radcliffe Institute conference,
Reproductive Health in the Twenty-first Century, in October 2004,
"Some women struggle for basic reproductive technologies, like a clinic
where sterile conditions might be. available to perform C-sections, while
others tum to cutting·edge genetic techniques" (quoted in Drexler 2005 ).
African American studies scholar Marsha Darling similarly writes, "This
stunning array of biotechnology is being directed at developing eugenical
population control strategies especially for low-income and poor women
of color globally," while "reproduction enhancement options under the
rubric of 'choice'" are reserved "for economically and racially privileged
women in

the global North" (2004b) .

While welf.tre reform laws aim to deter women receiving public assis

tance from having even one adclitional healthy baby (Mink 2002; Smith
2007), largely unregulated fertility clinics (Arons 2007, 1; Parens and
Knowles 2007) regularly implant privileged women with multiple em·
bryos, knowing the high risk multiple births pose for premature delivery
and low birth weight (Helmerhorst et a!.
al.

2004; Mundy 2007; Reddy et
2007). The public begrudges poor mothers a meager increase in ben

efits for one more cltild, but it celebrates the birth ofhigh-tech septuplet.<
that require a fortune in publicly supported hospital care (Andrews

1999,

55-61). The multibillion-dollar apparatus devoted to technologically fu,
cilitating affluent couples' procreative decisions stands in glaring contrast
to the high rate of infant death among black people, whicb remains more
than twice the rate for whites (Mathews and MacDorman

2007). Indeed,

the infant mortality rate is climbing in Mississippi and other southern
states (Eckholm

2007).

My prior writing on this reproductive caste system also contrasted pol·
ides that penalize poor blaek women's childbearing with the high-tech
fertility industry that promotes childbearing by more affluent whit<
women (Roberts

1998, 246-93). I recently reconsidered the positioning

of white women and women of color in the reproductive hierarchy, how·
ever (Roberts

2005 ) . Rather than place these women in opposition, I tied

them together in relation to the neoliberal trend toward privatization and

1

See the Reprogc:netics Web site

at

http://www.rcprogenetics.com/defuult.hunl.
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punitive governance. Both population control programs and genetic se
lection technologies reinforce biological explanations for social problems
and place reproductive responsibility on women, thus privatizing remedies
for illness and social inequity.
Population control ideology attributes social inequities to childbearing
by poor women of color, thereby legitimizing punitive regulation of these
women's reproductive decisions (Roberts 1998). Stereotypes of black fe
male sexual and reproductive irresponsibility support welfare reform and
law enforcement policies that severely regulate poor black women's sexual
and childbearing decisions (Neubeck 2001). By identifYing procreation
as the cause of deplorable social conditions, reproductive punishments
divert attention away from state responsibility and the need for social
change. Black mothers' crack use, for example, became a primary expla
nation for high rates of black infant mortality, although this disparity long
predated the crack epidemic (Roberts 1998, 154-59; Zerai and Banks
2002; McCaughey 2005 ).
Like punishments for poor women's childbearing, reprogenetics also
shifts responsibility for promoting well-being from the government to the
individual by malting women responsible for ensuring the genetic fitness
of their children. The individual woman becomes the site of governance
through self-regulation of genetic risk (Mykitiuk 2000). The medical
model of disability that promotes eugenic elimination of genetic risk in
stead of ending discrimination against disabled people supports state re
liance on individuals to secure their own well-being through the use of
genetic technologies. This diversion of attention away from social causes
and solutions reinforces privatization, the hallmark of a neoliberal state
that seeks to reduce social welfare programs while promoting the free
market conditions conducive to capital accumulation. Thus, reproductive
health policies involving women at opposite ends of the reproductive
hierarchy play an important role in the neoliberal state's transfer of services

from the welfare state

to the private {ealm of furnily and market.

In the last several years, while working on a book project exploring
the growth of biotechnologies that incorporate race as a genetic category,

I have come to reconsider once again the opposition of white women and
women of color in the reproductive caste system in relation to reproductive
technologies. The position I just described, like the 1980s reproductive
dystopias, still casts white women as the only consumers of reproductive
technologies and women of color only as victims of population control
policies. It assumes that white women are the only ones with access to
these technologies and that women of color play no part in the politics
of reprogenetics, except by their exclusion or exploitation.
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The recent expansion of both reproductive genetic screening and race
based biomedicine, however, signals a dramatic change in the racial politics
of reproductive technologies. First, the important role of genetic screen
ing, which makes individual citizens responsible for ensuring good health
by reducing genetic risk, may support the wider incorporation of repro
genetic technologies into the neoliberal health care system. Second, com
panies that market race-based biotechnologies now promise to extend the
benefits of genetic research to people of color (Bloche 2004; Kahn 2007).
Media promoting genetic technologies prominently feature people of
color in images representing the new genetic age, in contrast to prior
"
portrayals that emphasized whitene ss as the exclusive standard of genetic
fi.tness.2 Moreover, some clinics that offer high-tech reproductive services,
including PGD, explicitly appeal to clients of color.' Women of color

are

now part of the market and cultural imaginary of the new reprogenetics.
We need a new reproductive dystopia that accounts fur the changing racial
politics of genetics and reproduction.

In this article, I critically explore the role of race and racism in the
emergence of reproductive technologies that incorporate advances in ge
netic science. W hat are the implications of including women of color in
the market for reprogenetic technologies, particularly when this is done
with the expectation that women will use these technologies to manage
genetic risk/ In investigating this question, I hope to shed light on the
critical relationship between racism, neoliberalism, and reproduction.

Expanding the market for reproductive technologies

In

Killing the Black Body, I discussed the role of race in images promoting

the fertility industry (Roberts 1998, 251). I pointed out that pictures
shmving the success of reproduction-assisting technologies were alway<
of white babies, usually with blond hair and blue eyes, as if to highlight
their racial purity. When the New York Times launched

a

prominent fOur

article series called "The Fertility Market" in January 1996, for example,
the front page displayed a photograph of the director of a fertility clinic
surrounded by seven white children conceived tbere (Gabriel 1996, Al).

:z.

See the Web sites of DNA Tribes (http:/ /www.dnatribes.com}, GeneTree

(http://

www.generree.com), and National Geographic's Genographic Project (https:/ /www3
.nationalgeographk.com/genographic/index.html).
a

See the Pacific Fertility Center's appeal to prospective donors at http:/Jwww

.donatcyoureggs.com and information about egg donation at http:/jwww.pacifu:fertilityanter
.com/treat/agency_donation.php.
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The continuing page contained a picture of a set of beaming in vitro
fertilization (IVF) triplets, also white (Gabriel 1996, A18).
. In the 1990s, the only time black babies figured in media coverage of
these technologies -was in stories intended to evoke revulsion precisely
because of their race. One instance was a highly publicized lawsuit brought
by a white woman against a ferriliry clinic she claimed had mistakenly
inseminated her with a black man's sperm, resulting in the birth of a
mixed-race child (Schatz 1990; Sullivan 1990). Two reporters covering
the story speculated that "if the suit goes to trial, a jury could be faced
with the difficult task of deciding damages involved in raising an interracial
child" (Kantrowitz and Kaplan 1990). The perceived harm to the mother
of receiving the wrong sperm was intensified by the clinic's fuilure to
deliver a white baby.
Other notorious news stories from the 1990s included the case·of twin
boys born to a white Dutch couple who discovered when the babies were
two months old that one was white and one was black (Elliot and Endt
1995). The ferriliry clinic had fertilized the mother's eggs with sperm
from both her white husband and a black man. A landmark California
dispute from 1993, Johnson v. Calvert, involved a black gestational "sur
rogate," Aona Johoson, who was denied any rights to the child she bore
for the genetic parents, a white man and his Filipina wife, Mark and
Crispina Calvert! The press paid far more attention to Aona Johnson's
race than to that of Crispina Calvert. It also portrayed the baby as white.
By relying on the Calverts' genetic tie to the child to determine legal par
enthood, the California courts ensured that a black woman would not be
considered the natural mother of a white child (Roberts 1998, 280-81).
While the stories involving whites portrayed the positive potential of new
reproductive technologies, the stories involving women and childr�n of
color revealed their potential horror.
Today, however, the high-tech ferriliry business, including genetic
.screening services, no longer appeals. to an exclusively white clientele.
Although fertiliry clinics perform sex selection for a range of clients, the
controversy surrounding this service has centered on Chinese and Indian
women (Darnovsky 2004; Bumgarner 2007). Images on fertiliry clinic
'Web sites routinely show people of color alongside claims advertising clinic
services and their benefits. To be sure, pictures of white babies continue
to dominate. some Web sites. The home page of the Rinehart Center for
Reproductive Medicine in Illinois displays the head of a blond-haired baby
4

Johnson v. Calvert, 5 Cal. 4th 84, 19 Cal. Rptr. 494 (1993), cert. denied, 114 S. Ct.

206 (1993).
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emerging like the sun from billowing white clouds to illustrate its promise
of "turning your dreams of starting a family into reality."' Sher Institutes
for Reproductive Medicine, with nationwide locations, streams photo
strips of its "success stories," showing dozens of children, all of whom
appear to be white.•
Similarly, a full-page advertisement for the Virginia-based Genetics and
IVF Institute, whieh recently appeared in the New York Times Magazine,
features a giant photo (taking up about half the space) of a white baby
with blonde hair, blue eyes, and rosy cheeks.' The headline asks, "Over
40 and thinking of having a baby?" followed by the solution: "DONOR
EGG

Immediate Availability." In the text below, the company boasts of

offering "Doctoral Donors with advanced degrees and numerous other
donors with special accomplishments and talents." The assumption that
whiteness, intelligence, and talent are connected and hereditary remains
robust in the reprogenetic marketplace.
Nevertheless, the images associated with reproductive technologies
have dramatically diversified in recent years. Reproductive Health Spe
cialists in Illinois displays a photograph of a large group of white couples
holding white babies, captioned "Baby Picnic. "8 But its Web site also
contains a photograph of a smiling black man and woman and a drawing
of a pregnant black woman attended to by a black male partner and female
physician. Likewise, Houston IVF's Web site shows a beaming black cou
ple holding a black baby9 The Illinois-based Karande and Associates takes
a very multicultural approaeh, using a photo of a pregnant East Asian
woman for scheduling an appointment, a black woman and child for its
link to donor egg information, and a South Asian man and child for the
insurance information link. 10

There are numerous advertisements on craigslist.com explicitly solic-

' See the runehart Center for Reproductive Medicine Web site at http://www
.illinoisivf.corn.
6

See the Sher Institutes for Reproductive Medicine Web site at http:/jwww.Mveababy

.com/ss/index_ss.cfin?&city= local&site = ss2.
? See Genetics and IVF Institute, advertisement, New York Times MtVJ4zine, July 29,
2007,21.
1

See images of the "baby picnic" at http:/fwww.reproductivespecialist.com/baby_parties

.htm.
9

See rhe Houston IVF Web site at http://Mvw.housronivt:netjhoustonivfjOurScrvkes/

OurSer vices.asp.
HI

For images from the Karande and Associates Web site, see http://www.ka.randei\f

.com/appointment.html, http'/ jwww.karandeivf.com/eggdonorprogram.html, and http://
www.karandeivf.oomfinsurance.html.
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iring egg donors of color. For example, a posting by Beverly Hills Egg
Donation notes, "ALL ETHNICITIES WELCOME! "11 F. Williams Donor Ser
vices' listing states, "Ethnic Diverse Egg Donors Needed" and includes
a photo of an Asian, a white, and a black woman.12 Happy Beginnings,
LLC, advertises, "EGG DONORS WANTED ALL ETIINIC BACKGROUNDS,"
specifYing, "WE HAVE A VERY HIGH DEMAND FOR JEWISH, EAST INDIAN,
MIDDLE EASTERN, ASIAN, ITALIAN, AND BLONDE DONORS. "13 Similarly,

Pacific Fertility Center boasts that it "maintains a diverse egg donor da
tabase including Jewish egg donors, Asian egg donors, and a variety of
backgrounds and ethnidries. "14
Some fertility clinic Web sites not only market their reprogenetic ser
vices to people of color, but they also perform race-based genetic testing
as part of those services. Pacific Fertility Center's Web site includes the
statement, "Genetic screening is also recommended, based on ethnic back
ground.'ns
Reproductive Genetics Institute in Chicago similarly includes race in
the factors it takes into account in its genetic testing: "Screening Results
and Accuracy: By combining the results of the ultrasound and blood test
along with the age, race and weight of the mother, a number can be
generated by computer which represents the risk of the pregnancy being
affected by Down syndrome or another chromosome problem. Experience
has shown that, together, the ultrasound and blood screen will identify
6
approximately 90% of babies with chromosome abnormalities. " 1
Fertility clinics' use of race in generic selection procedures may help
to reinforce the erroneous belief that race is a biological classification that
can be determined generically or that generic traits occur in human beings
according to their race. Social scientists' demonstration that race is an
invented social grouping was confirmed by genomic studies of human
variation, including the Human Genome Project, showing high levels of

11

See Beverly Hills Egg Donation, advertise�ent, Los Angeles craigslist.com, SF Valley,

etcetera jobs, November 22, 2008.
12
See F. Williams Donor Services, advertisement, Inland Empire craigslist.com, etcetera
jobs, November 24, 2008.
13

See Happy Beginnings, LLC, advertisement, Reno craigslist.com, etcetera jobs, No

vember 13, 2008.

14 See the Pacific Fertility Center's appeal to prospective donors at http://www
.donateyoureggs.com.
15

See the Pacific Fertility Center's Web site at http://www.pacificfertilitycenter.com/

treat/agency_donation.php.
16
See the Reproductive Genetics Institute's Web page on first trimester screening at
http:/ /www.reproductivegenetics.com/firsLtrimester.html.
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genetic similarity among people of all races (Graves 2001; Cooper, Kauf
man, and Ward 2003 ) At the onset of the Human Genome Project, some
.

scholars believed that the science of human genetic diversity would replace
race as the preeminent means of grouping people for scientific purposes
.
(Lewontin 1995; Reardon 2005). Yet the use of race as a biological cat
egory in generic research and biotechnology is intensifYing (Burchard et

al. 2003; Bonham, Warshauer-Baker, and Collins 2005; Duster 2005).
The marketing of higb-tech reproductive services to women of color
is part of a broader inclusion of minority groups in the testing and pro
duction of cutting-edge biotechnologies. In June 2005, the Food and
Drug Administration (FDA) approved the first race-based pharmaceutical,
BiDil, to treat heart failure specifically in African American patients (Saul
2005) BiDil is the combination of two generic drugs that doctors were
.

already prescribing regardless of race. Yet the FDA permitted its maker,
Nitromed, to market BiDil as a drug for black people. Making BiDil race
specific also allowed Nitromed to extend its patent to the year 2020,
giving the company market exclusivity and the potential to reap huge
profits on drug sales (Kahn 2004). The manufacturer's unproven theory
supporting the need for a race-specific therapy is that the reason for higher
mortality rates among black heart patients lies in genetic differences
among "races,,, in either the reason for getting heart disease or the reason
for responding differently to medications for it (Kahn 2004; Sankar and

Kahn 2005).
BiDil is only one example of the growing trend toward "the strategic
use of race as a genetic category to obtain patent protection and drug
approval" (Kahn 2006, 1349). In his survey of gene-related patent ap
plications, legal scholar Jonathan Kahn discovered that the use of race has
increased fivefold in the past twenty years (2006). Claims about justice
in scientific research have shifted away from protecting socially disadvan
taged subjects from unethical practices and toward promoting access to
clinical trials and biotech products (Epstein 2007). There is strong support
for racial therapeutics among some black advocates, researchers, and phy
sicians precisely to redress past discrimination and fulfill long-standing
demands for science to attend to the health needs of African Americans
(Puckrcin 2006; see Roberts 2008). This increased commercial and pop
ular demand for race-specific pharmaceuticals threatens to reinforce a fulse
belief in the biological origin of race.

.

Advanced reproductive technologies similarly constitute a form of race
based medicine. Rather than serve an exclusively white clientele, fertility
clinics are marketing genetic technologies to women of color on the basis
of race and ethnicity and incorporating race in genetic-screening proce-

S IG N 5

Summer :ZCI09

791

dures. Contemporary reproductive dystopias, then, should not categori
cally exclude women of color from their imagined users of genetic selection
technologies. As I explain below, the expansion of race-based biotech
·nology, including genetic selection, fits within the neoliberal trend toward
privatization and punitive governance and requires adjusting feminist re
productive dystopias.

Neoliberalism and reproductive dystopia

The marketing of reprogenetics to women of color is taking place in the
conte:<t of neoliberal shifts in governance that may encourage the expan
sion of genetic-screening technologies to a broader clientele. Widespread
prenatal testing has already generated greater surveillance of pregnant
women and assigned them primary responsibility for making the "right"
genetic decisions. It is increasingly routine for pregnant women to get
prenatal diagnoses for certain genetic conditions such as Down syndrome
or dwarfism (Powell 2007; Saxton 2007). It is also often expected that
they will opt for abortion to select against any disabling traits identified
by genetic testing. Many obstetricians provide these tests without much
explanation or deliberatiou because they consider such screenings to be
a normal part of treating their pregnant patients. The director of repro
ductive genetics at a large Detroit hospital reported that at least half of
the women referred there with an abnormal amniocentesis result were
"uncertain about why they even had the test" (Consumers Union 1990,
486). Moreover, current tort case law creates incentives in favor of genetic
testing by imposing legal duties on obstetricians to offer it (Wei! 2006,
52; Ossorio 2007, 330). Wbile there are virtually no legal consequences
for doctors who encourage genetic tests, doctors who fail to use them
may be liable for damages in "wrongful birth" lawsuits.17
Although genetic counseling should be nondirective, many counselors
show disapproval when patients decid� against selective abortion. A ge
netic counselor asked a woman who decided to bear a child with Down
syndrome, "Wbat are you going to say to people when they ask you how
you could bring a child like this into the world/" (quoted in Helm, Mir1'

For example, the Supreme Court of Ohio recently held that parents of an unhealthy

child born following negligent failure to diagnose a fetal defect or.disease may bring suit

malpractice principles for the costs arising from the pregnancy and
&hirmer P: Mt. Auburn Dbstctria and Gynecologic A.tsociatts1 Inc., 108

under traditionaJ medical
birth of the child:

Ohio St. 3d 494, 2006-0hio-942 (Ohio S. Ct. 2006). Fo r an argument in favor of using
tort law to compensatefor "procreative injury" caused by reproduction assisting technologies,
see Kleinfeld (2005).

I
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anda, and Chedd

1998, 59). Brian Skotko's survey of985 mothers who

received postnatal diagnoses of Down syndrome for their children similarly
discovered that many of the mothers were chastised by health care pro
fessionals for not ':"'dergoing prenatal testing:
"Right after [my child] was born, the doctor flat out told my hus
band that this could have been prevented or discontinued at an
earlier stage of the pregnancy," wrote one mother who had a child
with DS in

2000. A mother who had a child in 1993 recalled, "I

had a resident in the recovery room when I learned that my daughter
had DS. When I started to cry, "I overheard him say, 'What did she
expect? She refused prenatal testing.'" . . . Another mother re
ported, from her experience in

1997, "The attending neonatologist,

rather than extending some form of compassion, lambasted us for
our ignorance in not doing prior testing and for bringing this burden
to society-noting the economical, educational, aQ.d social hardships
he would bring." Regarding a postnatal visit, a mother who had a
child in

1992 wrote, "[My doctor] stressed 'next time' the need for

amniocentesis so that I could 'choose to terminate."' (2005, 70-71)

As a result of such pressure, many pregnant women now view genetic
testing as a requirement of responsible mothering (Harmon

2007).

Poor women, especially women of color, currently face financial and
other barriers to receiving high-tech infertility services (Elster 2005). Be
cause genetic screening is now considered an essential part of preventive
medicine, however, these technologies are becoming integrated into social
welfare systems and private insurance schemes and are likely to become
increasingly available to poor and low-income women (Van den Daele

2006; Bumiller 2009).18 Unlike IVF, whose primary purpose is to increase
fertility, PGD functions to help women avoid starting a pregnancy that
entails disfuvored genetic traits (Franklin and Roberts

2006,

xx,

97).19

The ain1 of IVF is to produce the birth of a live baby; the aim of PGD
and fetal diagnosis is to prevent the birth of certain children. While gov
ernment welfare systems have disdained fucilitating childbearing by poor
women of color by declining to fund fertility treatnlents, they may there
fore treat genetic testing differently.
111

Foe an extensive review of insurance coverage ofinfertility treatments, sec Aeons {2007,

8-13): "Fourteen states currendy require some types of health insurance plans to include
coverage of certain infertility services or to make such coverage available" (8).
111

PGD also serves to increase fertility when it is undertaken to improve IVF success

rates (Franklin and Roberts 2006, 97).
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'The current ban on federal funding ofabortion places a significant limit
on state genetic selection programs (Powell 2007, 49-50). In states that
do not provide Medicaid funding for abortion, poor women can receive

sta te-sponsor ed genetic te sti ng but have o
t pay for the cost of sel ec tv
i e
abortions themselves. Yet it is not hard to foresee future federal and state
legislation that exempts "therapeutic" abortions based on genetic testing
from the ban on abortion funding. Prior to the 1973 passage of Roe v.

Wade, upholding the constitutional right to abortion, many states per
mitted therapeutic abortionsrecommended by physicianswhile criminal
izing elective abortions sought by women with unwanted pregnancies
,.

(Schoen 2005, 153-86).
Indeed, some clients of reprogenetics have claimed moral superiority
over women who have had abortions for nonselective reasons. In a July
22, 2004, op-ed piece in the New York Times, Barbara Ehrenreich calls
on women who had aborted fetuses based on prenatal diagnosis to support
the general right to abortion (2004). She notes that these women some

l

times distinguish themselves from womenwho have"ordinary" abortions.
One woman who aborted a fetus with Down syndrome states, "I don't
look at it as though I had an abortion, even though that is technically
what it is. There's a difference. I wanted this baby" (quoted in Ehrenreich
2004, A21). On a Web site for a support group called "A Heart breaking
Choice" a

mother whowent to an abortio n clinic complains, "I r esent ed

the fact that I had to be there with all these girls that did not want their
babies" (quoted in Ehrenreich 2004, A2l) . The incorporation of eugenic
values in arguments for women's reproductive freedom neglects the his
tory of abortion regulation, which limited women's reproductive freedom
by distinguishing between approved therapeutic and disapproved elective
abortions. An attempt to solicit supporters of selective abortion to join
the cause of abortion rights misunderstands the nature of reproductive
politics in the neoliberal age.
The expansion of genetic research apd technologies has helped to create
a new biological citizenship that enlists patients to take unprecedented
authority over their health at the molecular level (Rose 2007). According
to British sociologist Nikolas Rose, "our very biological life itself has
e nre red

the doniain of decision and choice" (2007, 40). Some scholars

have highlighted the enhancement of human agency, as "patients are in
creasingly urged to become active and responsible consumers of medical
services and products ranging from pharmaceuticals to reproductive tech
nologies and genetic tests" (2007, 4) and to form alliances with physicians,

scientists, and clinicians o
t advocate o
f r their interests (Franklinand Rob
erts 2006, xvii).
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Biological citizenship also reflects the shift of responsibility for public
welfare from the state to the private realms of market and family. As Rose
observes, responsibility for the management of health and reproduction
has devolved from the "formal apparatus of the government" to "quasi
,
autonomous regulatory bodies' such as bioethics commissions, profes
sional groups, and private corporations (2007, 3). Selling genetic testing
products directly to consumers is big business for private fertility clinics
and biotechnology companies. Biomedical research and technology have
correspondingly become major sources of capital accumulation, aided by
federal patents on genetic information, FDA approval of pharmaceuticals,
and public funding of lucrative private research ventures, such as Cali
fornia's stem cell research initiative.
In this neoliberal context, genetic testing serves as a form of privati
zation that makes the individual the site of governance through the self
regulation of genetic risk (Mykitiuk 2000). Reproductive genetic tech
nologies, in particular, introduce a new gendered division of labor and
surveillance as women bear the brunt of reprogenetics' contribution to
the neoliberal restructuring of health care (Mykitiuk 2000). Canadian legal
scholar Roxanne Mykitiuk points out that, contrary to the deregulation
that typically occurs in the service of big business, the new duties imposed
on women constitute a reregulation that supports capital investment in
market-based approaches to health care and other social needs while state
investment in public resources shrinks (2000).
In addition, reprogenetics incorporates a seemingly benign form of
eugenic thinking in its reliance on reproductive strategies to eliminate ,
genetic risk rather than social strategies to eliminate systemic inequities. �
Some disability rights advocates oppose prenatal genetic diagnosis that
leads to discarding embryos and fetuses predicted to have disabilities because these procedures devalue people who have disabilities, sending the
message that they should never have been born (Wendell1996,151-56;
Parens andAsch 2007; Saxton 2007). They argue that although disabilities
cause various degrees of impairment, the main difficulty in having a dis
ability stems from pervasive discrimination. "Rather than improving the
medical or social situation of today's and tomorrow's disabled citizens,"
write bioethicists Erik Parens and Adrienne Asch, "prenatal diagnosis re
inforces the medical model that disability itself, not societal discrimination
against people with disabilities, is the problem to be solved" (2007, 13).
The reasons why some parents do not want a disabled child are varied.
Wbilo some women may use genetic selection in an upwardly mobile quest
for the "perfect child," others want to prevent their children from suffering
the pain, illness, and physical limitations that accompany disabilities or

�
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worry that they are not capable of dealing with rlisability's social conse
quences (Wendell
Baily

1996, 82-83; Franklin and Roberts 2006, 132-62;
2007). Yet given merlical professionals' implicit rlirective favoring

genetic selection and powerful stereotypes that negatively depict disabled
people, many women are left with a false impression of the nature of
parenting a disabled child and the quality of disabled people's lives (which
·

genetic testing cannot predict; Bumiller 2009). Pregnant women are rarely
able to make truly informed decisions about what to do with test results
because they, obstetricians, and counselors typically have little information
about the lives of disabled people and their f.unilies (Wendell1996,
Parens and Asch

2007, 33-37).20

81-84;

Moreover, some of the undesirable events likely to happen to a child
with a serious disability that parents may reasonably wish to prevent, such
as limited educational and employment opportunities, are caused by social
as much as physical impediments (Steinbock 2007,

119). Unable to count

on societal acceptance or support, many women feel compelled to turn
to genetic testing to ensure their children's welfare (Lippman
Kittay

2007, 181 ) .

1991, 39;

With'out judging the morality of individual women's

decisions, we must critically evaluate the social, political, and legal incen
tives for genetic testing as well as consequences of genetic testing for
people with disabilities. Building on the disability critique, we must also
question the role that the eugenic approach to disability plays in neoliberal
governance.
Rose, the British sociologist discussed above, rejects critical intellec

tuals' use of eugenics rhetoric to contest PGD and other aspects of con
temporary biological politics

(2007, 54-68). He

argues that the eugenics

practiced in the first half of the twentieth century was a particular bio

political strategy that sought to improve the population as a whole through
deliberate state action. This effort "to control the biological makeup of
the population" as a whole, he claims, rlistinguishes eugenics from the
new biopolitics' concern with the genetic health of individuals (2007,

56).

"What we have here, then, is not eugellics but is shaped by forms of self
government imposed by obligations of choice, the desire for self-fulfill
ment, and the wish of parents for the best Jives for their children," Rose
concludes

(2007, 69).

Rose dismisses the relevance of eugenics to contemporary biopolitics

�o A recent survey ofresearch on the experience of disability in families concluded, "There
is an increasingly dominant body of research that finds aggregate patterns of overall adjust
ment and well-being to be similar across groups of families with and without children with
disabilities" (Ferguson, Gartner, and Lipsky 2007, 85).
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too categorically. He downplays eritical aspects of the past eugenics regime
that characterize both contemporary population control policies and ge
netic-screening technologies such as PGD. By eugenic thinking or values,

I refer to the belief that reproductive strategies can improve society by
reducing the births of socially marginalized people. The eugenic approach
to social problems locates them in reproduction rather than social structure
and therefore seeks to solve them by eliminating disfuvored people instead
of social inequities. Its chief

epistemological

device is to make the social

order seem natural by casting its features as biological facts. As Donald
MacKenzie observes, eugenic theory is "a way of reading the structure
of social classes onto nature"

(1981; 18). Programs based on such a belief

set up standards for reproduction that subsume childbearing under pre
vailing hierarchies of power.
Eugenics did not function only "in the service of a biological struggle
between nation-states" (Rose 2007, 66); it functioned to maintain the
racial, gender, and class order 'vithin the nation. (Moreover, alliances
between American and Nazi eugenicists in the 1930s show a \villingness

/

'

to cross national boundaries in the interest of white supremacy. )21 Thus,
contemporary proposals to solve social problems by curbing black repro
duction, such as the Philadelphia Inquirers suggestion to distribute the
long-acting contraceptive Norplanc as a remedy for black poverty, are
similar to past eugenic

policies in

that they make racial inequality appear

to be the product of nature rather than power (Kimelman

1990).

By

identifYing procreation as the cause of black people's condition, they divert
attention away from the political, social, and economic forces that maintain
the U.S. racial order. I therefore believe it is accurate and helpful to identity
the ways in which contemporary reproductive health policies incorporate
essential features of eugenic ideology, despite the important differences
that Rose highlights.
Futhermore, the distinction between past state-imposed and current
voluntary programs is not as clear-cut as Rose suggests. On the one hand,
Rose ignores the system of punitive governance that accompanies the
neoliberal shift to individual self-governance. Welfare is no longer a system
of aid but rather a system of behavior modification that attempts to regulate the sexual, marital, and childbearing decisions of poor unmarried
mothers by placing conditions on the receipt of state assistance (Roberts

n

When the leading American eugenicist, Harry Laughlin, received an honorary degree

from the University of Heiddberg in 1936, he wrote to German officials that the award
represented "evidence of a common understanding of German and American scientists of
the nature of eugenics" (quoted in Kevles 1985, 118).
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1998; Mink 2002; Smith 2007). Meanwhile, federal and state govern
ments aggressively intervene in marginalized communities to manage their
social deprivation with especially punitive measures. The U.S. prison pop
ulation has grown to proportions unprecedented in the history of Western
democracies, as an astounding number of young black men are locked up
(Garland 2001; the Sentencing Project 2005). The racial disparity in the
foster care population mirrors that of the prison system, as child protection
authorities remove grossly disproportionate numbers of black children
from their homes (Roberts 2002). Population control policies that at
tribute social inequities to the childbearing of poor minority women are
a critical component of this punitive trend away from state support for
fumilies and communities (Roberts 1998; Smith 2007). Rose's reference
to "the enabling state, the fucilitating state, the state as animator" (2007,
63) does not apply to policies designed to penalize childbearing by poor
women and women of color.
On the other hand, Rose's focus on state direction of twentieth-century
eugenic programs obscures the crucial role of private enterprises in dis
seminating and implementing eugenics. Just as influential as the man
datory sterilization Jaws passed in most states were the campaigns waged
by private groups such as the American Eugenics Society, the Human
Betterment Association, and the American Genetics Association to educate
the American public about the benefits of eugenics, as well as the American
Birth Control League's programs to distribute birth control to the unfit
(Kevles1985). As Rose acknowledges, "Eugenics was not disreputable or
marginal: it defined one dimension of mainstream thinking about the
responsibilities of politicians, protessionals, scientists, and inclividuals in
the modern, world" (2007, 59).
Some feminists who use eugenics rhetoric to critique modern genetic
selection technologies explicitly acknowledge the distinction between
state-imposed programs and private decisions made by individuals. For
example, U.S. sociologist Barbara Katz Rothman calls the marketing of
prenatal diagnostic technologies a for� of microeugenics, focused on the
individual, in contrast to macroeugenics, focused on populations (2001 ).
I also explicitly distingnish between population control policies and those
that promote reprogenetics while drawing attention to their common
support of neoliberal approaches to social inequities (Roberts 2005). This
distinction, however, should not eclipse the coercive.. nature and social
function of contemporary repro genetics (Wendell1996,156; Ward 2002).
As I discuss above, genetic selection procedures are increasingly treated
as social responsibilities reinforced not only by cultural expectations but
also by legal penalties and incentives. Does the state-supported repro-
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ductive genetics industry exist only to give individual citizens more re
productive choices, or, as Laura Hershey asks, is it uprimarily for rhe
benefit of a society unwilling to support disability-related needs?" (1994,
3 1 ; see also Wendell l996, 154).
Rose's analysis of contemporary biopolitics helps to illuminate rhc rad
ical change from state management ofthe population's healrh to individual
management of genetic risk, aided by new genetic technologies. These
technologies facilitate rhe shift from state responsibility for ensuring health
and welfare to private responsibility, all wirhin the context of persistent
race, gender, and class inequities; devastating reductions in social pro
grams; and intense state surveillance of marginalized communities. Ge
netic screening is increasingly recommended not only to avoid having
children wirh serious early onset disabilities or diseases wirh a high like
lihood of occurring but to eliminate rhe risk of developing certain diseases
as an adult (Obasogie 2006). A recent article in rhe Journal of the Amer

ican Medical Association, for example, encouraged families affected by
hereditary cancer syndromes, including breast, ovarian, and colon cancer,
to use PGD to screen out embryos genetically predisposed to develop
cancer (Offit, Sagi, and Hurley 2006). In rhe neoliberal future, rhe state
may rely on rhe expectation that all pregnant women will undergo genetic
testing to legitimize not only its refusal to support rhe care of disabled
children but also its denial of broader claims for public provision ofhealrh
care.

Extending choice to women of color
The role reprogenetics plays in neoliberalism's inregrated system of pri
vatization and punitive governance is obscured by liberal notions of re
productive choice. Despite rhe potential for reprogenetics to diminish
public healrh care and intensifY regulation of women's reproductive de
cisions, its sponsors often defend the industry's immunity from state reg
ulation in rhe name of women's reproductive freedom (Rorhman 1989,
116; Darling 2004a). Extending rhe availability of genetic selection tech
nologies to women of color does not correct rhe role played by repro
genetics in advancing a neoliberal agenda. Tbe depletion of public re
sources for general healrh care and for supporting people with disabilities
would exacerbate economic inequities along racial lines, hitting poor mi
nority communities rhe hardest. In addition, rhe expectation of genetic
self-regulation may fall especially harshly on black and Latina women, who
are stereotypically defined as lacking rhe capacity for self-control. The use
of high-tech, expensive technologies by a privileged slice of women of
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color suggests that those who do not use them for financial, social, or
ethical reasons may be blamed for the social consequences.
There may always be certain reproductive technologies that are reserved
for the wealthiest people and are outside the reach of most women of
color. The market will privilege a tiny elite among people of color who
can afford high-tech reproductive innovations while relegating the vast
majority to the state's most intense reproductive surveillance. Indeed, the
neoliberal reification of market logic is likely to expand the hiring of poor
and low-income women of color for their reproductive services. The in
cidence of payments to these women to gestate fetuses or to produce eggs
for genetic research could intensify (Haworth 2007) even as they are
encontaged to use genetic technologies to screen their own children.

In addition, marketing race-based biotechnologies to consumers of
color can reinforce the biological meaning of race. By incorporating in
vented racial categories into genetic research, scientists and entrepreneurs
are producing biotechnologies that validate people's belief that race is a
natural classification. A renewed trust in inherent racial differences pro
vides an alternative explanation for persistent gross inequities in blacks'
health and welfare despite the end of de jure discrimination. These tech
nologies promote the view that deepening racial inequities that result from
neoliberal policies are actually caused by genetic differences between
whites and other racialized groups. The biological explanation for racial
disparities provides a ready logic for the staggering disenfranchisement of
people of color through mass incarceration and other punitive policies,
as well as the perfect complement to color-blind policies implementing
the claim that racism has ceased to be the cause of their predicament.
Including women of color in the market for reprogenetic technologies
does not eradicate the racial caste system underlying reproductive strati
fication.
A reproductive dystopia for the twenty-first century could no longer

exclude women of color from the market for high-tech reprogenetics.
Rather, it would take place in a society in which racial and economic
divisions are reinforced by the genetic testing extended to them. In this
new dystopia, the biological definition of race is stronger

than ever, val

idated by genetic science and cemented in popular culture by race-based
biotechnologies. The state has disclaimed all responsibility for supporting
its citizens, placing the duty of ensuring public welfare in all women's
self-regulation ofgenetic risk. The medical model of disability is embedded
in a neoliberal health policy that relies on widespread use of genetic tech
nologies to disqualifY citizens from claiming public support and to avoid
the need for social change. The new biologization of race may seem to
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unite blacks, and other nonwhite "races," by confirming the genetic uni
formity of people belonging to the same race and their genetic difference
from others. In the new dystopia, however, genetic selection technologies
that incorporate race as a biological category reinforce class divisions be
tween elite people of color who can afford the full array of high-tech
procedures and the masses who snffer most from neoliberal policies bol
stered by these very biological explanations of racial inequities. But I can
also imagine a new utopia arising from feminists' radical resistance to
enlisting women as genetic screeners in service of a neoliberal agenda, a
resistance that is emboldened by new alliances-joining reproductive jus
tice with antiracist, disability rights; and economic justice movements that
recognize their common interest in contesting a race-based reprogeneti.c
future.
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